Sector Update: Healthcare Shares Mixed Pre-Market; Isis Pharmaceuticals Jumps 6% on Study of Muscular Atrophy Treatment

Shutterstock photo

Healthcare stocks:

JNJ: -0.57%

PFE: +0.16%

ABT: flat

MRK: +0.32%

AMGN: +0.62%

Healthcare shares were mixed in pre-market trade Friday.

In healthcare stocks news, Isis Pharmaceuticals ( ISIS ) shares were up 6% after it said a study of its ISIS-SMN Rx drug in children with spinal muscular atrophy showed an average increase of 3.7 points observed in muscle function score.

The children were treated with 9 pm of the drug, which also showed dose-dependent increases in SMN protein levels in children treated with ISIS-SMNRx from both single- and multiple-dose studies. Isis said the drug was well tolerated at all dose levels.

And, Teleflex Inc. ( TFX ), a provider of medical technology products, said Q4 adjusted profit rose 18.3%, topping analysts' forecasts, helped by the acquisitions of Vidacare and LMA International, a gain in average selling prices and new products.

Q4 adjusted diluted earnings per share from continuing operations were $1.36, compared to $1.15 in the prior year period. That's above the $1.27 analyst estimate, according to Capital IQ.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities
Referenced Symbols: ISIS , TFX

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities
Follow on:

Research Brokers before you trade

Want to trade FX?

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by